Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Barinthus Biotherapeutics (BRNS) Return on Assets (2021 - 2025)

Barinthus Biotherapeutics' Return on Assets history spans 5 years, with the latest figure at 0.64% for Q4 2025.

  • For Q4 2025, Return on Assets fell 29.0% year-over-year to 0.64%; the TTM value through Dec 2025 reached 0.64%, down 29.0%, while the annual FY2025 figure was 0.51%, 19.0% down from the prior year.
  • Return on Assets reached 0.64% in Q4 2025 per BRNS's latest filing, down from 0.64% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.03% in Q3 2022 to a low of 0.64% in Q4 2025.
  • Average Return on Assets over 5 years is 0.27%, with a median of 0.28% recorded in 2021.
  • Peak YoY movement for Return on Assets: grew 20bps in 2022, then plummeted -36bps in 2023.
  • A 5-year view of Return on Assets shows it stood at 0.18% in 2021, then soared by 111bps to 0.02% in 2022, then plummeted by -1795bps to 0.33% in 2023, then dropped by -6bps to 0.35% in 2024, then crashed by -83bps to 0.64% in 2025.
  • Per Business Quant, the three most recent readings for BRNS's Return on Assets are 0.64% (Q4 2025), 0.64% (Q3 2025), and 0.51% (Q2 2025).